InvestorsHub Logo
Followers 30
Posts 2778
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Monday, 04/15/2019 1:25:44 PM

Monday, April 15, 2019 1:25:44 PM

Post# of 977
In this paper it was shown that TTI-621 can trigger macrophage-mediated phagocytosis of Sézary cells and reduces tumour burden in patients following IV administration. Four of five heavily pre-treated patients had a decrease in the dominant malignant clone and other markers of tumour burden after a single infusion http://www.bloodadvances.org/content/3/7/1145